ClinicalTrials.Veeva

Menu

Group B Streptococcus Infection and PROM Incidince

A

Assiut University

Status

Not yet enrolling

Conditions

Group B Streptococcal Infection
Premature Rupture of Fetal Membranes

Treatments

Drug: To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

Study type

Observational

Funder types

Other

Identifiers

NCT06735703
GBS WITH PROM

Details and patient eligibility

About

To investigate incidince of prom with GBS infection and role of prophylaxis against it

Enrollment

150 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women with prom after 34 wks festation

Exclusion criteria

  • Bleeding disorder
  • emergency conditions

Trial design

150 participants in 1 patient group

Pregnant women after 34 wks with PROM
Treatment:
Drug: To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

Trial contacts and locations

0

Loading...

Central trial contact

Dina Mohamed Kamel; Sherif Abdelmeged badran

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems